A novel, noninvasive eye imaging system able to detect pathological markers of Alzheimer’s disease (AD) has been presented in a proof-of-concept study from researchers at Cedars-Sinai Medical Center (CA, USA) and NeuroVision LLC (CA, USA).

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please Login or Register to view this area.